Publications by authors named "Anyin Yang"
Hepatocellular carcinoma (HCC) is a malignant tumor. It is estimated that approximately 50-80% of HCC cases worldwide are caused by hepatitis b virus (HBV) infection, and other pathogenic factors have been shown to promote the development of HCC when coexisting with HBV. Understanding the molecular mechanisms of HBV-induced hepatocellular carcinoma (HBV-HCC) is crucial for the prevention, diagnosis, and treatment of the disease.
View Article and Find Full Text PDFArticle Synopsis
- A new noninvasive prediction model was developed to aid in diagnosing autoimmune hepatitis, moving away from reliance on liver biopsies.
- The model was created using data from 1,288 patients and identified nine key variables (like ALT, IgG, and age) that help predict the risk of autoimmune hepatitis.
- The nomogram model showed strong effectiveness in predicting the disease, with high accuracy measured through internal and external validation.
Background: Complications and diagnostic efficiency for liver biopsy are main concerns for clinicians. This study aimed to assess the safety and efficacy of transjugular liver biopsy (TJLB) compared with percutaneous liver biopsy (PLB) when patients had equal level of liver function and number of passes, using propensity score matching (PSM).
Methods: The clinical and pathological data of patients who received TJLB or PLB between January 2012 and October 2022 were collected.
Hepatocellular carcinoma is one of the most common cancers with the characteristics of invasion and high mortality. Current forms of prevention remain severe. is widely used in traditional Chinese medicine treatment of various tumors.
View Article and Find Full Text PDFBackground: Aberrant cytokeratin 7 expression by hepatocytes (CK7Hs) is the hallmark characteristic of cholestasis diseases, especially in ductopenia diseases such as primary biliary cholangitis (PBC). This study attempted to evaluate the differences and relationships between the clinical and histological features of aberrant cytokeratin 7 (CK7) expression by hepatocytes in PBC patients.
Methods: The clinicopathological data of patients diagnosed with PBC at the Second Hospital of Nanjing between January 2016 and September 2018 were analysed with SPSS 20.